Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EVOPLASTEC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.0% 1.1% 1.0% 1.0% 1.2% 2.2% 7.7% 7.7%   Credit score (0-100)   87 83 85 86 80 67 32 32   Credit rating   A A A A A BBB BB BB   Credit limit (kDKK)   1,300.6 858.0 1,292.6 1,539.5 689.8 1.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   154 185 176 186 17.6 57.8 0.0 0.0   EBITDA   154 185 176 186 17.6 57.8 0.0 0.0   EBIT   -0.0 30.7 124 186 17.6 57.8 0.0 0.0   Pre-tax profit (PTP)   1,026.8 1,233.3 1,951.4 1,683.0 1,696.1 5.2 0.0 0.0   Net earnings   1,066.6 1,202.4 1,830.2 1,626.3 1,539.3 -34.2 0.0 0.0   Pre-tax profit without non-rec. items   1,027 1,233 1,951 1,683 1,696 5.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   205 51.3 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   23,407 24,499 26,216 27,728 29,208 29,113 23,651 23,651   Interest-bearing liabilities   65.1 0.5 83.0 0.0 752 2,186 0.0 0.0   Balance sheet total (assets)   23,514 24,555 26,328 27,757 29,983 31,502 23,651 23,651   Net Debt   -4,345 -1,528 -341 -1,060 -144 1,284 -23,651 -23,651     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   154 185 176 186 17.6 57.8 0.0 0.0   Gross profit growth   65.3% 19.9% -4.9% 6.2% -90.6% 228.3% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   23,514 24,555 26,328 27,757 29,983 31,502 23,651 23,651   Balance sheet change%   4.6% 4.4% 7.2% 5.4% 8.0% 5.1% -24.9% 0.0%   Added value   154.0 184.6 175.6 186.4 17.6 57.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -308 -308 -103 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -0.0% 16.6% 70.8% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.9% 5.4% 7.7% 6.5% 5.9% 3.3% 0.0% 0.0%   ROI %   4.9% 5.4% 7.7% 6.5% 5.9% 3.3% 0.0% 0.0%   ROE %   4.7% 5.0% 7.2% 6.0% 5.4% -0.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   99.5% 99.8% 99.6% 99.9% 97.4% 92.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -2,822.5% -827.4% -194.4% -568.6% -816.2% 2,220.4% 0.0% 0.0%   Gearing %   0.3% 0.0% 0.3% 0.0% 2.6% 7.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   275.9% 175.9% 16.6% 151.7% 0.1% 69.5% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   92.2 190.7 58.3 141.6 3.9 1.3 0.0 0.0   Current Ratio   92.2 190.7 58.3 141.6 3.9 1.3 0.0 0.0   Cash and cash equivalent   4,410.5 1,528.2 424.4 1,060.2 896.1 901.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   9,743.3 10,527.4 6,194.6 3,775.6 1,732.3 202.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0